Healthcare ❯ Pharmaceuticals

Vaccine Development

Clinical Trials COVID-19 Vaccines mRNA Technology mRNA Vaccines Nasal Spray Vaccines COVID-19 Covid-19 Public Health Regulatory Approval Market Competition Vaccine Efficacy Future Vaccines Bavarian Nordic Covid-19 Vaccine Approval Emergency Use Authorization AstraZeneca Market Impact Vaccine Safety Moderna Protein-based Vaccines International Cooperation Legal Issues Vaccine Manufacturing Regulatory Affairs Regulatory Oversight Research and Development Regulatory Agencies Adverse Effects Covid-19 Vaccines Collaboration

FDA Approves XFG-Targeted COVID Vaccines for Older and High‑Risk Americans

Manufacturers are shipping doses now while formal CDC season guidance is unresolved, leaving access and coverage rules to states and providers.

Moderna’s Phase 3 Melanoma Win Reprices the Company

Pfizer and BioNTech Halt U.S. COVID Vaccine Trial for 50–64-Year-Olds Over Slow Enrollment

FDA Weighs Ending Pfizer COVID-19 Authorization for Children Under 5

Moderna Cuts 10% of Global Workforce in Major Cost Overhaul

FDA Approves Moderna’s mNEXSPIKE for Seniors and High-Risk Adults as CDC Drops Recommendations for Healthy Children and Pregnant Women

FDA Grants Limited Approval to Novavax’s COVID-19 Vaccine